Matthew Watson

Matthew Watson

Auto-generated profile, based on publicly available information

Matthew Watson

Department of Computer Science, Durham University, Durham, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in JMIR Medical Informatics
Verified
Journal Article
Open access
ZZZheming Zuo
Zheming Zuo
MWMatthew Watson
Matthew Watson
DBDavid Budgen
David Budgen
RHRobert Hall
Robert Hall
CKChris Kennelly
Chris Kennelly
NMNoura Al Moubayed
Noura Al Moubayed
Background: Data science offers an unparalleled opportunity to identify new insights into many aspects of human life with recent advances in health care. Using data science in digital health raises significant challenges regarding data privacy, transparency, and trustworthiness. Recent regulations enforce the need for a clear legal basis for collecting, processing, and sharing data, for example, the European Union’s General Data Protection Regulation (2016) and the United Kingdom’s Data Protection Act (2018). For health care providers, legal use of the electronic health record (EHR) is permitted only in clinical care cases. Any other use of the data requires thoughtful considerations of the legal context and direct patient consent. Identifiable personal and sensitive information must be sufficiently anonymized. Raw data are commonly anonymized to be used for research purposes, with risk assessment for reidentification and utility. Although health care organizations have internal policies defined for information governance, there is a significant lack of practical tools and intuitive guidance about the use of data for research and modeling. Off-the-shelf data anonymization tools are developed frequently, but privacy-related functionalities are often incomparable with regard to use in different problem domains. In addition, tools to support measuring the risk of the anonymized data with regard to reidentification against the usefulness of the data exist, but there are question marks over their efficacy.Objective: In this systematic literature mapping study, we aim to alleviate the aforementioned issues by reviewing the landscape of data anonymization for digital health care.Methods: We used Google Scholar, Web of Science, Elsevier Scopus, and PubMed to retrieve academic studies published in English up to June 2020. Noteworthy gray literature was also used to initialize the search. We focused on review questions covering 5 bottom-up aspects: basic anonymization operations, privacy models, reidentification risk and usability metrics, off-the-shelf anonymization tools, and the lawful basis for EHR data anonymization.Results: We identified 239 eligible studies, of which 60 were chosen for general background information; 16 were selected for 7 basic anonymization operations; 104 covered 72 conventional and machine learning–based privacy models; four and 19 papers included seven and 15 metrics, respectively, for measuring the reidentification risk and degree of usability; and 36 explored 20 data anonymization software tools. In addition, we also evaluated the practical feasibility of performing anonymization on EHR data with reference to their usability in medical decision-making. Furthermore, we summarized the lawful basis for delivering guidance on practical EHR data anonymization.Conclusions: This systematic literature mapping study indicates that anonymization of EHR data is theoretically achievable; yet, it requires more research efforts in practical implementations to balance privacy preservation and usability to ensure more reliable health care applications.

24 May 2021 in JMIR Medical Informatics
Verified
Journal Article
Open access
ZAZakhriya Alhassan
Zakhriya Alhassan
MWMatthew Watson
Matthew Watson
DBDavid Budgen
David Budgen
RARiyad Alshammari
Riyad Alshammari
AAAli Alessa
Ali Alessa
NMNoura Al Moubayed
Noura Al Moubayed
Background: Predicting the risk of glycated hemoglobin (HbA1c) elevation can help identify patients with the potential for developing serious chronic health problems, such as diabetes. Early preventive interventions based upon advanced predictive models using electronic health records data for identifying such patients can ultimately help provide better health outcomes. Objective: Our study investigated the performance of predictive models to forecast HbA1c elevation levels by employing several machine learning models. We also examined the use of patient electronic health record longitudinal data in the performance of the predictive models. Explainable methods were employed to interpret the decisions made by the black box models. Methods: This study employed multiple logistic regression, random forest, support vector machine, and logistic regression models, as well as a deep learning model (multilayer perceptron) to classify patients with normal (<5.7%) and elevated (≥5.7%) levels of HbA1c. We also integrated current visit data with historical (longitudinal) data from previous visits. Explainable machine learning methods were used to interrogate the models and provide an understanding of the reasons behind the decisions made by the models. All models were trained and tested using a large data set from Saudi Arabia with 18,844 unique patient records. Results: The machine learning models achieved promising results for predicting current HbA1c elevation risk. When coupled with longitudinal data, the machine learning models outperformed the multiple logistic regression model used in the comparative study. The multilayer perceptron model achieved an accuracy of 83.22% for the area under receiver operating characteristic curve when used with historical data. All models showed a close level of agreement on the contribution of random blood sugar and age variables with and without longitudinal data. Conclusions: This study shows that machine learning models can provide promising results for the task of predicting current HbA1c levels (≥5.7% or less). Using patients’ longitudinal data improved the performance and affected the relative importance for the predictors used. The models showed results that are consistent with comparable studies.

18 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MWMatthew Watson
Matthew Watson
BHBashar Awwad Shiekh Hasan
Bashar Awwad Shiekh Hasan
NMNoura Al Moubayed
Noura Al Moubayed
It has been shown that identical deep learning (DL) architectures will produce distinct explanations when trained with different hyperparameters that are orthogonal to the task (e.g. random seed, training set order). In domains such as healthcare and finance, where transparency and explainability is paramount, this can be a significant barrier to DL adoption. In this study we present a further analysis of explanation (in)consistency on 6 tabular datasets/tasks, with a focus on Electronic Health Records data. We propose a novel deep learning ensemble architecture that trains its sub-models to produce consistent explanations, improving explanation consistency by as much as 315% (e.g. from 0.02433 to 0.1011 on MIMIC-IV), and on average by 124% (e.g. from 0.12282 to 0.4450 on the BCW dataset). We evaluate the effectiveness of our proposed technique and discuss the implications our results have for both industrial applications of DL and explainability as well as future methodological work.

4 December 2024 in BMJ Health & Care Informatics
Verified
Journal Article
Open access
PDF file
MWMatthew Watson
Matthew Watson
SLStelios Boulitsakis Logothetis
Stelios Boulitsakis Logothetis
DGDarren Green
Darren Green
MHMark Holland
Mark Holland
PCPinkie Chambers
Pinkie Chambers
NMNoura Al Moubayed
Noura Al Moubayed
Objectives: Increasing operational pressures on emergency departments (ED) make it imperative to quickly and accurately identify patients requiring urgent clinical intervention. The widespread adoption of electronic health records (EHR) makes rich feature patient data sets more readily available. These large data stores lend themselves to use in modern machine learning (ML) models. This paper investigates the use of transformer-based models to identify critical deterioration in unplanned ED admissions, using free-text fields, such as triage notes, and tabular data, including early warning scores (EWS). Design: A retrospective ML study. Setting: A large ED in a UK university teaching hospital. Methods: We extracted rich feature sets of routine clinical data from the EHR and systematically measured the performance of tree- and transformer-based models for predicting patient mortality or admission to critical care within 24 hours of presentation to ED. We compared our proposed models to the National EWS (NEWS). Results: Models were trained on 174 393 admission records. We found that models including free-text triage notes outperform structured tabular data models, achieving an average precision of 0.92, compared with 0.75 for tree-based models and 0.12 for NEWS. Conclusions: Our findings suggests that machine learning models using free-text data have the potential to improve clinical decision-making in the ED; our techniques significantly reduce alert rate while detecting most high-risk patients missed by NEWS.

2 November 2024 in BMJ Oncology
Verified
Journal Article
Open access
PDF file
MWMatthew Watson
Matthew Watson
PCPinkie Chambers
Pinkie Chambers
LSLuke Steventon
Luke Steventon
JKJames Harmsworth King
James Harmsworth King
AEAngelo Ercia
Angelo Ercia
NMNoura Al Moubayed
Noura Al Moubayed
Objectives: Routine monitoring of renal and hepatic function during chemotherapy ensures that treatment-related organ damage has not occurred and clearance of subsequent treatment is not hindered; however, frequency and timing are not optimal. Model bias and data heterogeneity concerns have hampered the ability of machine learning (ML) to be deployed into clinical practice. This study aims to develop models that could support individualised decisions on the timing of renal and hepatic monitoring while exploring the effect of data shift on model performance. Methods and analysis: We used retrospective data from three UK hospitals to develop and validate ML models predicting unacceptable rises in creatinine/bilirubin post cycle 3 for patients undergoing treatment for the following cancers: breast, colorectal, lung, ovarian and diffuse large B-cell lymphoma. Results: We extracted 3614 patients with no missing blood test data across cycles 1–6 of chemotherapy treatment. We improved on previous work by including predictions post cycle 3. Optimised for sensitivity, we achieve F2 scores of 0.7773 (bilirubin) and 0.6893 (creatinine) on unseen data. Performance is consistent on tumour types unseen during training (F2 bilirubin: 0.7423, F2 creatinine: 0.6820). Conclusion: Our technique highlights the effectiveness of ML in clinical settings, demonstrating the potential to improve the delivery of care. Notably, our ML models can generalise to unseen tumour types. We propose gold-standard bias mitigation steps for ML models: evaluation on multisite data, thorough patient population analysis, and both formalised bias measures and model performance comparisons on patient subgroups. We demonstrate that data aggregation techniques have unintended consequences on model bias.

19 March 2026 in Communications Medicine
Verified
Journal Article
Open access
PDF file
MWMatthew Watson
Matthew Watson
TWThomas Winterbottom
Thomas Winterbottom
THThomas Hudson
Thomas Hudson
BJBenedict Jones
Benedict Jones
HSHubert P. H. Shum
Hubert P. H. Shum
NMNoura Al Moubayed
Noura Al Moubayed
Background Skin cancer is one of the most prevalent cancers globally, with early detection critical to ensure reduced mortality risk. To aid early detection, machine learning (ML) skin cancer detection models have been proposed, currently with a focus on dermatoscopic imaging only. However, freetext may provide extra diagnostic information that is not present in images alone. Methods We constructed a multimodal dataset comprising 5481 dermatoscopic images from 4538 patients, including patient metadata and clinical notes, with binary labels (benign vs. malignant, 7% malignant). To assess and mitigate bias from leading language, we developed a clinical text preprocessing pipeline combining regular expressions and large language models, enabling multiple levels of filtering. We train multimodal ML models on this dataset to explore the effect of freetext on model performance. Results Our results show that incorporating unfiltered text significantly improves classification performance (0.970 AUROC) compared to visual data alone (0.909 AUROC); even with leading language removed, performance gains persist (0.948 AUROC). Conclusions This work benchmarks clinical freetext inclusion in skin lesion classification, demonstrating that clinical text contributes predictive value beyond that available in images alone. The model’s high performance on unfiltered clinical text highlights the high levels of bias, and possible shortcutting, present in this text which may make it unsuitable for inclusion in some ML models. By systematically filtering clinical notes via our proposed technique, we show that multimodal models retain improved accuracy while reducing bias. These results provide practical guidance for integrating clinical text into real-world skin cancer detection systems and establish a foundation for future multimodal research in dermatology.